Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.
Requires public schools to develop policy for administration of nasal seizure rescue medication and use of manual vagas nerve stimulators for students with seizure disorder on emergent basis.